ImaCor Inc. receives Health Canada license for the selling of the ImaCor Zura™ system and ClariTEE™ probe in Canada.

Contact: Dipak Rajhansa
ImaCor, Inc.
Phone: 516-393-0970

For Immediate Release

ImaCor Inc. receives Health Canada license for the selling of the ImaCor Zura™ system and ClariTEE™ probe in Canada.

Uniondale, NY (September 22, 2009)—ImaCor Inc., developer of the ClariTEE™ probe for transesophageal echocardiography (TEE) monitoring, announces...

About ImaCor

ImaCor Inc. is a privately held company headquartered in Uniondale, NY. The company designs, manufactures, and distributes advanced solutions for TEE monitoring in the critical care environment for the purpose of improving patient outcomes. The Company manufactures the ClariTEE ™ probe, the only miniaturized, indwelling probe for TEE monitoring. ZuraTM and ClariTEETM are trademarks of ImaCor, Inc. For more information, please visit our website at www.imacormonitoring.com